We sought in this study to examine the relationship between microalbuminuria and cardiac geometry since a slight increased urinary albumin excretion (UAE) and increased left ventricular (LV) mass have both been identified as predictors of cardiovascular events in hypertensive subjects. 
Introduction
A slightly elevated urinary albumin excretion (UAE), termed microalbuminuria, has been identified as an independent predictor of cardiovascular disease in major population-based cohort studies. 1, 2 Indeed, it is well established that microalbuminuria can be considered predictive of the development of overt proteinuria and of cardiovascular mortality in diabetic patients. 3 The same adverse prognostic conclusion seems to emerge from recent research in tively correlated to LVMI (r = 0.46, P Ͻ 0.001) and relative wall thickness (r = 0.47, P Ͻ 0.001). In the entire population, normal LV geometry, concentric LV remodelling, eccentric and concentric LV hypertrophy was found in 34%, 33%, 12% and 21%, respectively. The prevalence of normal LV geometry was significantly higher in normoalbuminuric compared with microalbumnuric subjects (55 vs 14%, P Ͻ 0.001) while the prevalence of concentric LV hypertrophy was significantly higher in microalbuminuric compared with normoalbuminuric subjects (32 vs 5%, P Ͻ 0.0001). Multiple regression analysis revealed that concentric LV hypertrophy was significantly associated with increased values of UAE and mean arterial pressure. In conclusion, the higher prevalence of unfavourable LV geometric patterns in hypertensive subjects with microalbuminuria compared with those without microalbuminura, may account for the worse cardiovascular outcomes associated with the presence of an increased UAE in hypertensive subjects. non-diabetic patients with essential hypertension. 1, 2, [4] [5] [6] The pathogenic mechanisms leading microalbuminuric patients to this increased risk are still unknown; several studies have demonstrated an association between microalbuminuria and atherogenic cardiovascular risk factors, endothelial dysfunction, impaired aortic mechanics and increased left ventricular (LV) mass. 2, [5] [6] [7] [8] Left ventricular hypertrophy is another manifestation of pre-clinical disease with well-defined prognostic meaning for cardiovascular complications. Furthermore, identification of various geometric patterns of LV hypertrophy furthers stratifies cardiovascular risk. 9, 10 The aim of the present study, therefore, was to examine the relation between microalbuminuria and the patterns of LV geometry in untreated nondiabetic hypertensive subjects.
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Subjects and methods
Study population
The population in our study consisted of subjects with essential hypertension, aged 30 and 70 years referred to the outpatient hypertension unit. Patients with uncomplicated essential hypertension, stages I-II were included in the study if they were newly diagnosed (within the previous 2 years) and had never been previously treated. Presence and severity of hypertension were determined on the basis of office blood pressure (BP) measurements obtained by sphygmomanometer during three consecutive visits scheduled 3 weeks apart, according to the recommendations of the JNC-VI. 11 To confirm essential hypertension, patients were assessed by using conventional clinical criteria and laboratory tests. In addition, all patients underwent renal ultrasonography to confirm the presence of normal kidney size without cortical scarring or signs of obstructive uropathy. Exclusion criteria included overt proteinuria, detectable by urine dip strip test, diabetes mellitus, increased values of plasma creatinine, familiar hypercholesterolaemia, history of any cardiac disease or other clinically significant concurrent medical condition. Women receiving oral contraceptives or long-term oestrogen replacement therapy were also excluded. Of the 310 individuals screened for the study, 249 subjects (142 males), mean age 52 ± 10 years, fulfilled all inclusion and exclusion criteria and consisted our study population.
All patients gave written informed concept for participation. The study protocol was approved by the ethics committee of our institution.
Determination of UAE
The study patients were asked to collect three nonconsecutive 24-h urine samples (from 8 am to 8 am) for the determination of UAE, as has been previously described. 7 Urinary albumin concentrations were determined by an immunonephelometric technique with a limit of detection of 0.4 mg/dl and an interassay variation of 3.5%. Based on mean UAE in the samples, the study patients were divided in those with microalbuminuria (mean UAE 20-200 mg/24 h) and in those without microalbuminuria (mean UAE Ͻ20 mg/24 h).
In addition to the above initial laboratory workup, all selected patients underwent measurement of plasma lipids, which included total cholesterol, high-density lipoprotein cholesterol and triglycerides, using established techniques. Finally, patients were questioned about their smoking habbits. Smokers were identified as those patients consuming one or more cigarettes per day.
Cardiac ultrasonography
All echocardiographic studies were performed by a senior echocardiographer using a Hewlett-Packard Sonos 2500 ultrasound imager equipped with a 2.25-5 MHz transducer. Images were recorded on super VHS videotapes and measurements were subsequently performed off-line by two independent operators, blinded to the patients' demographics and BP status. Two-dimensional guided M-mode echocardiography was performed at the parasternal longaxis view, and LV end-systolic systolic and end-diastolic dimension, as well as intraventricular septum and posterior wall thickness were measured as the mean from five consecutive cardiac cycles, in accordance to the recommendations of the American Society of Echocardiography. 12, 13 Subsequently, relative wall thickness was calculated using the following formula: (septal wall thickness + posterior wall thickness)/(LV end-diastolic diameter).
14,15 LV mass was calculated by the formula introduced by Devereux et al: (0.80 × 1.04[{intraventricular septum thickness + posterior wall thickness + left ventricular end diastolic diameter} 3 − left ventricular end diastolic diameter] + 0.6) and was indexed for the body surface area (LVMI). LV hypertrophy was considered present if LVMIϾ104 g/m 2 in women and Ͼ116 g/m 2 in men. 15, 16 Normal geometry was considered when LV mass did not extend the above gender specific values. Concentric LV hypertrophy was considered present if relative wall thickness was Ͼ0.43 and eccentric LV hypertrophy when relative wall thickness was р0.43. 15 Concentric remodelling was considered present in patients with normal LVMI and relative wall thickness р0.43.
The inter-observer variability in our laboratory was 9.65% for LVMI and 8.5% for relative wall thickness. Measurements obtained by the two observers were averaged and used for data analysis.
Statistical analysis
Data is expressed as mean ± s.d. Since the 24-h UAE data were skewed, values were logarithmically transformed prior to statistical testing. Significant differences between the two groups were determined using the Student's independent samples t-test or the 2 test where appropriate. Multiple linear regression analysis, with inclusion criteria at the 0.01 level and exclusion criteria at the 0.05 level, was used to evaluate the relation of clinical, demographic and haemodynamic parameters with LVMI. Also, a logistic regression model was used to identify significant relations between each type of LV geometry and clinical, demographic and haemodynamic parameters. Spearman correlation was performed to determine correlations between any of the parameters. An analysis of covariance (ANCOVA) was performed in order to detect significant differences of LVMI between patients with and without microalbuminuria, after the adjustment of a number of covariates which were linearly related to the dependent variable. All tests were considered to be significant at the level of P Ͻ 0.05. 
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Results
Of the 249 studied subjects, 130 subjects (53%) had normal UAE (9.8 ± 4 mg/24 h) and the remaining 119 subjects (47.8%) had increased UAE (43.3 ± 31 mg/24 h). The demographic and clinical characteristics of all subjects included in the study are presented in Table 1 . The subjects with and without microalbuminuria were similar with respect to age, sex, body mass index, smoking status, plasma rennin activity, plasma total cholesterol, triglycerides, high-density lipoprotein cholesterol levels and rate of clearance of creatinine. The systolic BP, diastolic BP, mean arterial pressure (diastolic plus 1/3 × pulse pressure) and pulse pressure values were significantly higher in the microalbuminuric than the normoalbuminuric hypertensive patients. LV echocardiographic measurements are presented in Table 2 . The two groups did not differ regarding the LV end-systolic and end-diastolic diameter. In contrast, patients with microalbuminuria had significantly greater LVMI (by 21 g/m 2 ) and relative wall thickness (by 0.05) compared to patients without microalbuminuria.
In the entire study population, the log of 24-h UAE was positively correlated with LVMI (r = 0.46, was performed in the entire study population in order to evaluate the relation between LVMI and various haemodynamic and demographic parameters. It was demonstrated that age, office mean arterial pressure and log 24-h UAE were significantly and independently related with LVMI in this setting ( Table 3 ).
The distribution of subjects with each type of LV geometric pattern in the groups with and without microalbuminuria is listed in Table 4 . The prevalence of patients with normal LV geometry was significantly lower in subjects with microalbuminuria compared with those without microalbuminuria while the prevalence of patients with concentric LV hypertrophy was significantly higher in subjects with microalbuminuria compared with those without microalbuminuria (Figure 2 ). Subjects with concentric LV hypertrophy had significantly increased values of log 24-h UAE compared with subjects with eccentric LV hypertrophy, concentric LV remodelling and normal LV geometry (1.581, 1.340, 1.301 and 1.013, respectively, P Ͻ 0.001 for all cases). Similarly, subjects with eccentric LV hypertrophy and concentric LV remodelling exhibited significantly increased values of log 24-h UAE in comparison with subjects with normal LV geometry (P Ͻ 0.005 for both cases).
Furthermore, each type of LV geometry as a dependent variable was entered in a logistic regression model in order to identify significant relations with age, body mass index, mean arterial pressure and log 24-h UAE. It was revealed that normal LV geometry was significantly related with age (␤ = −0.041, Wald = 7.97, P = 0.004), mean arterial pressure (␤ = −0.040, Wald = 5.32, P = 0.02) and log 
Discussion
In the present study we evaluated the relationship of microalbuminuria with cardiac geometric patterns in untreated patients with mild to moderate essential hypertension. Our main finding was that hypertensive subjects with microalbuminuria exhibit higher incidence of unfavourable LV geometric patterns compared with those without microalbuminuria. Absence of microalbuminuria is associated with normal LV geometric pattern, while the presence of microalbuminuria is associated with concentric LV hypertrophy pattern.
In recent years a great deal of interest has focused on microalbuminuria and its relation to cardiovascular complications. Evidence accumulates indicating a close relationship of microalbuminuria with cardiovascular events in patients with essential hypertension.
1,2,4-6 Accordingly, it was recently established that microalbuminuria confers a fourfold increased risk of ischaemic heart disease among hypertensive or bordeline hypertensive subjects. 1 The described association of increased UAE with LV hypertrophy 6, 8 may explain some of the prognostic significance of microalbuminuria. Indeed, in our study, higher indexed LV mass was found in microalbuminuric subjects than in normoalbuminuric individuals. Most notably, the difference in LVMI between microalbuminuric and normoalbuminuric hypertensive subjects remains statistically significant after adjustment for age, mean arterial pressure and body mass index. To further investigate this issue we examined the association of various cardiac geometric patterns to UAE in our hypertensive population. Thus, a great percentage of patients with normoalbuminuria had normal LV geometry while patients with microalbuminuria had higher percentage of concentric LV hypertrophy. Our findings are in agreement with a previous study 17 in which there was a significant trend towards increased prevalence of LV hypertrophy, especially of the concentric type in patients with higher degrees of albuminuria. However, in this study the definition of LV geometric pattern was not based on gender-specific criteria and the presence of microalbuminuria was estimated in only one first morning urine sample.
Morbid events occur almost four times more frequently in subjects with concentric hypertrophy than in those with normal LV geometry. 18, 19 Krumholz et al, 14 demonstrated that LV geometry can be used as an independent factor for risk stratification of hypertensive patients.
14 Findings of the present study suggest that the unfavourable association of microalbuminuria with cardiovascular events can be explained at least in part from these high-risk geometric patterns. Concentric hypertrophy is an adaptive response of cardiac muscle to pressure overload which mainly depends on the elasticity of aorta and the other large arteries. Furthermore, it has been hypothesised that microalbuminuria is a marker of Journal of Human Hypertension endothelial dysfunction and increased vascular permeability that might predispose to greater penetration of atherogenic lipoprotein particles into arterial wall. 20, 21 Towards this end, we have previously reported that microalbuminuria is associated with excess impairment of large arteries mechanics in essential hypertension, 7 a state which is closely related with LV structural and functional changes. 22 So, it is reasonable to suggest that microalbuminuria is closely related with unfavorable LV geometric patterns through its widespread damage of the arterial tree.
Both increased LV mass and proteinuria are the 'final common pathways' of many adverse effect on the heart and kidney respectively. Assessment of LV hypertrophy and UAE rate can identify preclinical cardiovascular disease in asymptomatic hypertensive patients. 23 The observation that microalbuminuric patients are accompanied by a higher incidence of LV concentric hypertrophy may have some clinical implications in the treatment of hypertensive individuals. Accurate detection of early renal dysfunction by using a simple, specific and rather inexpensive test for identification of microalbuminuria, may improve clinical risk stratification of hypertensive subjects. Microalbuminuria along with LV geometric patterns may potentiate each other's prognostic significance. Furthermore, converting enzyme inhibitors have been shown to reduce UAE along with the established regression of LV hypertrophy. 24 Our results, indicate that microalbuminuria is a strong reason for aggressive treatment of these patients.
An overview of the BP data in our population reveals that patients with microalbuminuria had higher values of both systolic and diastolic BP compared to those without microalbuminuria. This finding is in agreement with the majority of previous reports and is consistent with the concept that UAE largely reflects the prevailing BP levels in hypertensive patients. 8, 25 In contrast with some previous studies, 4, 6 the classical risk factors for atherosclerosis were equally distributed among patients with and without microalbuminuria in our study.
From a methodological viewpoint, there are some potential confounding factors in the present study. First, we did not calculate the UAE as a ratio of urinary albumin to urinary creatinine that might have enhanced the accuracy of the assessment of microabuminuria. However, we preferred our estimations to be based on three non-consecutive 24-h samples instead of using only a single spot urine sample. Second, the prevalence of microalbuminuria in our study group (47%) exceeded the high end of the range of reported rates in previous studies. This fact is likely accounted for the characteristics of this tertiary care centre population and for patient selection criteria according to the study protocol. In agreement with the above, 66% of our subjects had LV remodelling or hypertrophy.
Conclusions
Microalbuminuria is accompanied by unfavourable LV geometric patterns in untreated essential hypertensive subjects. This association may partially account for the greater risk for cardiovascular events in hypertensive subjects with microalbuminuria. However, further studies are needed to determine whether clinical outcome is improved or treatment cost is lowered by basing antihypertensive treatment decisions in part on the presence of microalbuminuria and unfavourable LV geometric patterns.
